Abstract
Jasmonates are a class of plant hormones with many agricultural
applications and potential medicinal properties. However, the low
content of jasmonates in plants and environmental issues with their
production make their supply challenging. In the present study, we
report the de novo microbial biosynthesis of jasmonic acid and its
derivatives, methyl jasmonate and jasmonoyl isoleucine, from glucose
using an engineered baker’s yeast. The study uses enzymes located in the
endoplasmic reticulum and cytosol to generate the intermediates
α-linolenic acid and cis-12-oxophytodienoic acid. Our final
engineered stain, which integrates 15 heterologous genes from diverse
plants and fungi and had 3 of its native genes deleted, produces
jasmonic acid at titres of 19.0 mg l−1 in flask cultures
through in vitro supplementation of α-linolenic acid. In addition to the
well-known natural structures (−)-jasmonic acid and (+)-epi-jasmonic acid, the engineered yeast also synthesized the previously unobserved unnatural structures (+)-jasmonic acid and (−)-epi-jasmonic
acid. These results demonstrate that yeast is a scalable and
sustainable platform to produce both naturally occurring jasmonates and
those structures not found naturally in plants.
Original language | English |
---|---|
Journal | Nature Synthesis |
Volume | 3 |
Pages (from-to) | 224-235 |
DOIs | |
Publication status | Published - 2024 |